Oral ultrasound contrast agent + AI multi-agent diagnosis
Bringing tertiary hospital contrast enhancement capabilities to primary care and screening centers
Building a complete early screening system for gastric and pancreatic diseases based on oral ultrasound contrast agents + AI multi-agent diagnosis
AIMED = Two Agents + One Protocol + One System
Pancreatic + Gastrointestinal oral ultrasound contrast agents · Standardized examination protocol · AI multi-agent diagnosis platform
Drink contrast agent → Ultrasound examination → AI-assisted analysis → Report in 10 minutes
From contrast agents to AI diagnosis, building a complete gastric and pancreatic disease early screening system
Three types of contrast agents: pancreatic, gastrointestinal, and biliary. Safe and non-invasive, significantly improving ultrasound imaging quality.
Conductor commander + gastric/pancreas specialist agents. Four AI systems automatically switch to ensure uninterrupted diagnosis.
Medical knowledge base + intelligent image segmentation. Automatically retrieves similar cases before diagnosis to improve accuracy.
Identity registration on-chain, diagnosis reports NFT-ized, ensuring data tamper-proof and traceable.
Covering primary care to public health, building a comprehensive gastric and pancreatic disease early screening system
For patients with gastrointestinal symptoms at primary care level, conducting clinical diagnosis applications for gastric and pancreatic diseases.
Population-wide screening for asymptomatic healthy individuals, exploring the value of AI-assisted screening in health checkup scenarios.
Establishing regular follow-up mechanisms for high-risk groups such as chronic gastritis and gastric ulcer patients.
Cooperating with government public health programs to conduct regional gastric and pancreatic disease censuses.
Collaborating with top medical institutions and universities to promote clinical translation
Multi-modal medical image analysis, deep learning model optimization
High-quality case data and expert annotation, clinical technology translation
Symptomatic patient diagnosis applications, real-world scenario validation
Asymptomatic population screening, AI-assisted screening value validation
From technology validation to large-scale deployment
Gastric + Pancreas dual core, 5000+ annotated cases, AI accuracy ≥85%
Expand to bile duct + esophagus, Class II device registration, pilot hospital validation
NMPA Class III certificate application, covering primary medical institutions nationwide
No login required, experience AI diagnosis capabilities directly
Unified Entry · Multi-Role · Blockchain Identity · Digital Assets